OWLSTONE MEDICAL LTD is a limited company established in 2003 and currently active, operating from its headquarters at 183 Cambridge Science Park, Cambridge, CB4 0GA. The company’s SIC codes are -72190, reflecting its focus on research and experimental development within the natural sciences and engineering sectors. OWLSTONE specializes in providing bespoke analytical and modeling services to the medical and pharmaceutical industries. These services encompass data analysis, predictive modeling, and simulation, with a particular emphasis on optimizing drug development processes and clinical trial design. The company’s core expertise lies in utilizing advanced statistical techniques and computational modeling to address complex challenges related to disease progression, treatment efficacy, and patient outcomes. OWLSTONE’s international presence is currently limited, primarily focused on collaborations with research institutions and pharmaceutical companies globally. The company employs a team of skilled researchers and data scientists, and actively seeks to expand its international reach through strategic partnerships. The company’s hiring indicators suggest a commitment to attracting and retaining talented individuals within the scientific and technical fields.

OWLSTONE MEDICAL LTD is a limited company established in 2003 and currently active, operating from its headquarters at 183 Cambridge Science Park, Cambridge, CB4 0GA. The company’s SIC codes are -72190, reflecting its focus on research and experimental development within the natural sciences and engineering sectors. OWLSTONE specializes in providing bespoke analytical and modeling services to the medical and pharmaceutical industries. These services encompass data analysis, predictive modeling, and simulation, with a particular emphasis on optimizing drug development processes and clinical trial design. The company’s core expertise lies in utilizing advanced statistical techniques and computational modeling to address complex challenges related to disease progression, treatment efficacy, and patient outcomes. OWLSTONE’s international presence is currently limited, primarily focused on collaborations with research institutions and pharmaceutical companies globally. The company employs a team of skilled researchers and data scientists, and actively seeks to expand its international reach through strategic partnerships. The company’s hiring indicators suggest a commitment to attracting and retaining talented individuals within the scientific and technical fields.